Compare AU

Compare DRUG vs. IKO

Compare shares and ETFs on the ASX that you can trade on Pearler.

BetaShares Global Healthcare ETF - Currency Hedged

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the iShares MSCI South Korea ETF (IKO). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

DRUG

IKO

Popularity

Low

Low

Pearlers invested

64

9

Median incremental investment

$943.50

$990.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,978.96

$721.60

Average age group

26 - 35

> 35


Key Summary

DRUG

IKO

Strategy

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

IKO.AX was created on 2000-05-09 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to provide investors with the performance of the MSCI Korea 25/50 Index, before fees and expenses. The index is designed to measure the performance of Korean large-, mid- & small- capitalisation companies

Top 3 holdings

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

SAMSUNG ELECTRONICS LTD (21.37 %)

SK HYNIX INC (8.05 %)

HYUNDAI MOTOR (3.22 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Information Technology (31.22 %)

Industrials (16.72 %)

Financials (14.78 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.57 %

0.59 %


Key Summary

DRUG

IKO

Issuer

BetaShares

iShares

Tracking index

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

MSCI Korea 25/50 Index - AUD

Asset class

ETF

ETF

Management fee

0.57 %

0.59 %

Price

$8.53

$90.20

Size

$197.947 million

$122.302 million

10Y return

N/A

36.83 %

Annual distribution yield (5Y)

1.90 %

1.33 %

Market

ASX

ASX

First listed date

08/08/2016

15/11/2007

Purchase fee

$6.50

$6.50


Community Stats

DRUG

IKO

Popularity

Low

Low

Pearlers invested

64

9

Median incremental investment

$943.50

$990.50

Median investment frequency

Monthly

Monthly

Median total investment

$1,978.96

$721.60

Average age group

26 - 35

> 35


Pros and Cons

DRUG

IKO

Pros

  • Higher exposure to US market

  • Lower management fee

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Higher management fee

  • Lower price growth

  • Lower distribution yield

DRUG

IKO

Higher exposure to US market

Lower exposure to US market

Lower management fee

Higher management fee

Higher price growth

Lower price growth

Higher distribution yield

Lower distribution yield

Home